Correction: Microfluidic Platform for Single Nucleotide Polymorphism Genotyping of the Thiopurine S-Methyltransferase Gene to Evaluate Risk for Adverse Drug Events (Journal of Molecular Diagnostics (2007) 9(4) (521–529) (S1525157810604242) (10.2353/jmoldx.2007.070014));Microfluidic platform for single nucleotide polymorphism genotyping of the thiopurine s-methyltranferase gene to evaluate risk for adverse drug events

Journal of Molecular Diagnostics

Volumn 9, Issue 4, 2007, Pages 521-529

  Chowdhury, Jeeshan ^a   Kagiala, Govind V ^b   Pushpakom, Sudeep ^c   Lauzon, Jana ^a   Makin, Alistair ^d   Atrazhev, Alexey ^a   Stickel, Alex ^b   Newman, William G ^c   Backhouse, Christopher J ^b   Pilarski, Linda M ^a  

^a CROSS CANCER INSTITUTE   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE; METHYLTRANSFERASE; THIOPURINE S METHYLTRANSFERASE; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; DRUG SAFETY; ENTERITIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MICROCHIP ANALYSIS; MICROFLUIDIC ANALYSIS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 34548745746     PISSN: 15251578     EISSN: 19437811     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2017.03.001     Document Type: Erratum

References (49)

1. Kalow W, Tang BK, Endrenyi L: Hypothesis: comparisons of inter- and intra-individual variations can substitute for twin studies in drug research. Pharmacogenetics 1998, 8:283-289
2. Risch NJ: Searching for genetic determinants in the new millennium. Nature 2000, 405:847-856
3. McCarthy JJ, Hilfiker R: The use of single-nucleotide polymorphism maps in pharmacogenomics. Nat Biotechnol 2000, 18:505-508
4. Pirmohamed M, Park BK: Genetic susceptibility to adverse drug reactions. Trends Pharmacol Sci 2001, 22:298-305
5. Wang L, Weinshilboum R: Thiopurine S-methyltransferase, pharmacogenetics: insights, challenges and future directions. Oncogene 2006, 25:1629-1638
6. Whitesides GM: The origins and the future of microfluidics. Nature 2006, 442:368-373
7. Weinshilboum RM, Sladek SL: Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 1980, 32:651-662
8. Evans WE: Pharmacogenetics of thiopurine S-methyltransferase and thiopurine therapy. Ther Drug Monit 2004, 26:186-191
9. Lennard L, Gibson BE, Nicole T, Lilleyman JS: Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia. Arch Dis Child 1993, 69:577-579
10. Pierik M, Rutgeerts P, Vlietinck R, Vermeire S: Pharmacogenetics in inflammatory bowel disease. World J Gastroenterol 2006, 12:3657-3667
11. Clunie GP, Lennard L: Relevance of thiopurine methyltransferase status in rheumatology patients receiving azathioprine. Rheumatology (Oxford) 2004, 43:13-18
12. Meggitt SJ, Gray JC, Reynolds NJ: Azathoprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial. Lancet 2006, 367:839-846
13. Thervet E, Anglicheau D, Toledano N, Houllier AM, Noel LH, Kreis H, Beaune P, Legendre C: Long-term results of TMPT activity monitoring in azathioprine-treated renal allograft recipients. J Am Soc Nephrol 2001, 12:170-176
14. McLeod HL, Krynetski EY, Relling MV, Evans WE: Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia 2000, 14:567-572
15. Yates CR, Krynetski EY, Loennechen T, Fessing MY, Tai HL, Pui CH, Relling MV, Evans WE: Molecular diagnosis of thiopurine S-methyl-transferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med 1997, 126:608-614
16. Evans WE, Horner M, Chu YO, Kalwinsky D, Roberts WM: Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia. J Pediatr 1991, 119:985-989
17. Tai HL, Krynetski EY, Schuetz EG, Yanishevski Y, Evans WE: Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): mechanisms for the genetic polymorphism of TPMT activity. Proc Natl Acad Sci USA 1997, 94:6444-6449
18. Becquemont L: Clinical relevance of pharmacogenetics. Drug Metab Rev 2003, 35:277-285
19. Kirchheiner J, Fuhr U, Brockmoller J: Pharmacogenetics-based therapeutic recommendations - ready for clinical practice? Nat Rev Drug Discov 2005, 4:639-647
20. Woelderink A, Ibarreta D, Hopkins MM, Rodriguez-Cerezo E: The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies. Pharmacogenomics J 2006, 6:3-7
21. Chen X, Sullivan PF: Single nucleotide polymorphism genotyping: biochemistry, protocol, cost and throughput. Pharmacogenomics J 2003, 3:77-96
22. Footz T, Somerville MJ, Tomaszewski R, Sprysak KA, Backhouse, CJ: Heteroduplex-based genotyping with microchip electrophoresis and dHPLC. Genetic Testing 2003, 7:283-293
23. Tian H, Brody LC, Landers JP: Rapid detection of deletion, insertion, and substitution mutations via heteroduplex analysis using capillary-and microchip-based electrophoresis. Genome Res 2000, 10:1403-1413
24. Footz T, Somerville MJ, Tomaszewski R, Elyas B, Backhouse CJ: Integration of combined heteroduplex/restriction fragment length polymorphism analysis on an electrophoresis microchip for the detection of hereditary haemochromatosis. Analyst 2004, 129:25-31
25. Manage DP, Zheng Y, Sommerville MJ, Backhouse CJ: On-chip HA/SSCP for the detection of hereditary haemochromatosis. Microfluidics Nanofluidics 2005, 1:364-372
26. Vahedi G, Kaler K, Backhouse CJ: An integrated method for mutation detection using on-chip sample preparation, single-stranded conformation polymorphism, and heteroduplex analysis. Electrophoresis 2004, 25:2346-2356
27. Tian H, Emrich CA, Scherer JR, Mathies RA, Andersen PS, Larsen LA, Christiansen M: High-throughput single-strand conformation polymorphism analysis on a microfabricated capillary array electrophoresis device. Electrophoresis 2005, 26:1834-1842
28. Tian H, Brody LC, Fan S, Huang Z, Landers JP: Capillary and microchip electrophoresis for rapid detection of known mutations by combining allele-specific DNA amplification with heteroduplex analysis. Clin Chem 2001, 47:173-185
29. Erickson D, Liu X, Venditti R, Li D, Krull UJ: Electrokinetically based approach for single-nucleotide polymorphism discrimination using a microfluidic device. Anal Chem 2005, 77:4000-4007
30. Medintz I, Wong WW, Berti L, Shiow L, Tom J, Scherer J, Sensabaugh G, Mathies RA: High-performance multiplex SNP analysis of three hemochromatosis-related mutations with capillary array electrophoresis microplates. Genome Res 2001, 11:413-421
31. Pal R, Yang M, Lin R, Johnson BN, Srivastava N, Razzacki SZ, Chomistek KJ, Heldsinger DC, Haque RM, Ugaz VM, Thwar PK, Chen Z, Alfano K, Yim MB, Krishnan M, Fuller AO, Larson RG, Burke DT, Burns MA: An integrated microfluidic device for influenza and other genetic analyses. Lab Chip 2005, 5:1024-1032
32. Ng JK, Liu WT: Miniaturized platforms for the detection of single-nucleotide polymorphisms. Anal Bioanal Chem 2006, 386:427-434
33. Ramsay G: DNA chips: state-of-the art. Nat Biotechnol 1998, 16:40-44
34. Verpoorte E: Beads and chips: new recipes for analysis. Lab Chip 2003, 3:60N-68N
35. Neuhoff V: Microelectrophoresis and auxilary micromethods. Electrophoresis 2000, 21:3-11
36. Spinney L: Getting started with SNPs. Scientist 2005, 19:22
37. Otterness D, Szumlanski C, Lennard L, Klemetsdal B, Aarbakke J, Park-Hah JO, Iven H, Schmiegelow, K, Branum E, O'Brien J, Weinshilboum R: Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms. Clin Pharmacol Ther 1997, 62:60-73
38. Spire-Vayron de la Moureyre C, Debuysere H, Sabbagh N, Marez D, Vinner E, Chevalier ED, Lo Guidice JM, Broly F: Detection of known and new mutations in the thiopurine S-methyltransferase gene by single-strand conformation polymorphism analysis. Hum Mutat 1998, 12:177-185
39. Schaeffeler E, Lang T, Zanger UM, Eichelbaum M, Schwab M: High-throughput genotyping of thiopurine S-methyltransferase by denaturing HPLC. Clin Chem 2001, 47:548-555
40. Haglund S, Lindqvist M, Almer S, Peterson C, Taipalensuu J: Pyrosequencing of TPMT alleles in a general Swedish population and in patients with inflammatory bowel disease. Clin Chem 2004, 50:288-295
41. Zhang R, Zhu Z, Zhu H, Nguyen T, Yao F, Xia K, Liang D, Liu C: SNP cutter: a comprehensive tool for SNP PCR-RFLP assay design. Nucleic Acids Res 2005, 33:W489-W492
42. Jaquenoud Sirot E, van der Velden JW, Rentsch K, Eap CB, Baumann P: Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance. Drug Saf 2006, 29:735-768
43. Ma XL, Zu P, Hu YM, Wu MY, Li ZG, Bu DF: [Exploration of methodology for assay of single nucleotide polymorphism in thiopurine methyltransferase gene.] Chinese. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2003, 11:458-463
44. Duffy DC, McDonald JC, Schueller OJA, Whitesides GM: Rapid prototyping of microfluidic systems in poly(dimethylsiloxane). Anal Chem 1998, 70:4974-4984
45. Kaigala GV, Huskins RJ, Preiksaitis J, Pang XL, Pilarski LM, Backhouse CJ: Automated screening using microfluidic chip-based PCR and product detection to assess risk of BK virus-associated nephropathy in renal transplant recipients. Electrophoresis 2006, 27:3753-3763
46. Footz T, Wunsam S, Kulak S, Crabtree HJ, Glerum DM, Backhouse CJ: Sample purification on a microfluidic device. Electrophoresis 2001, 22:3868-3875
47. Marcus JS, Anderson WF, Quake SR: Parallel picoliter RT-PCR assays using microfluidics. Anal Chem 2006, 78:956-958
48. Roper MG, Easley CJ, Landers JP: Advances in polymerase chain reaction on microfluidic chips. Anal Chem 2005, 77:3887-3893
49. Shinder GA, Manam S, Nichols WW: A sensitive restriction fragment length polymorphism method to detect CAA→AAA mutations at codon 61 of Ha-ras. Mol Carcinog 1993, 7:263-267